Journal
BRAIN COMMUNICATIONS
Volume 4, Issue 3, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/braincomms/fcac104
Keywords
RNS system; neuromodulation; imaginary coherence; functional connectivity; magnetoencephalography
Categories
Funding
- National Institutes of Health [TL1TR001871-05, T32EB001631, R01EB022717, R01NS100440, R01AG062196, R01DC013979, R01DC176960, R01DC017091, K08AG058749]
- DOD CDMRP grant [W81XWH1810741]
- Larry L. Hillblom Foundation [2019-A-013SUP]
- Alzheimer's Association [AARG-21849773]
- UCSF
- Doris Duke Physician Scientist Fellowship
- Ernest Gallo Foundation Distinguished Professorship in Neurology at UCSF
- Ricoh's MEG Research Group
- UCOP [MRP17-454755]
- U.S. Department of Defense (DOD) [W81XWH1810741] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
This study aimed to investigate whether non-invasively measured functional brain connectivity can predict clinical response to responsive neurostimulation therapy. The findings suggest that patients with lower global functional connectivity in the alpha and beta frequency bands are less likely to respond to neurostimulation therapy. Functional connectivity predicted responder status more strongly than hemispheric predictors, and lobar functional connectivity was not a predictor.
Responsive neurostimulation is a promising treatment for drug-resistant focal epilepsy; however, clinical outcomes are highly variable across individuals. The therapeutic mechanism of responsive neurostimulation likely involves modulatory effects on brain networks; however, with no known biomarkers that predict clinical response, patient selection remains empiric. This study aimed to determine whether functional brain connectivity measured non-invasively prior to device implantation predicts clinical response to responsive neurostimulation therapy. Resting-state magnetoencephalography was obtained in 31 participants with subsequent responsive neurostimulation device implantation between 15 August 2014 and 1 October 2020. Functional connectivity was computed across multiple spatial scales (global, hemispheric, and lobar) using pre-implantation magnetoencephalography and normalized to maps of healthy controls. Normalized functional connectivity was investigated as a predictor of clinical response, defined as percent change in self-reported seizure frequency in the most recent year of clinic visits relative to pre-responsive neurostimulation baseline. Area under the receiver operating characteristic curve quantified the performance of functional connectivity in predicting responders (>= 50% reduction in seizure frequency) and non-responders (<50%). Leave-one-out cross-validation was furthermore performed to characterize model performance. The relationship between seizure frequency reduction and frequency-specific functional connectivity was further assessed as a continuous measure. Across participants, stimulation was enabled for a median duration of 52.2 (interquartile range, 27.0-62.3) months. Demographics, seizure characteristics, and responsive neurostimulation lead configurations were matched across 22 responders and 9 non-responders. Global functional connectivity in the alpha and beta bands were lower in non-responders as compared with responders (alpha, p(fdr) < 0.001; beta, p(fdr) < 0.001). The classification of responsive neurostimulation outcome was improved by combining feature inputs; the best model incorporated four features (i.e. mean and dispersion of alpha and beta bands) and yielded an area under the receiver operating characteristic curve of 0.970 (0.919-1.00). The leave-one-out cross-validation analysis of this four-feature model yielded a sensitivity of 86.3%, specificity of 77.8%, positive predictive value of 90.5%, and negative predictive value of 70%. Global functional connectivity in alpha band correlated with seizure frequency reduction (alpha, P = 0.010). Global functional connectivity predicted responder status more strongly, as compared with hemispheric predictors. Lobar functional connectivity was not a predictor. These findings suggest that non-invasive functional connectivity may be a candidate personalized biomarker that has the potential to predict responsive neurostimulation effectiveness and to identify patients most likely to benefit from responsive neurostimulation therapy. Follow-up large-cohort, prospective studies are required to validate this biomarker. These findings furthermore support an emerging view that the therapeutic mechanism of responsive neurostimulation involves network-level effects in the brain. To prognosticate outcomes with neurostimulation for epilepsy, Fan et al. investigate functional network connectivity measured non-invasively with magnetoencephalography as a novel biomarker for effectiveness of responsive neurostimulation (RNS) therapy. Resting-state functional connectivity in alpha and beta frequency bands predicted response to subsequent RNS therapy and correlated with seizure frequency reduction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available